PMID: 6414004Jan 1, 1983Paper

L-Dopa and piribedil alter different components of attentional behavior dependent on dose

Psychopharmacology
M Cheal

Abstract

L-Dopa (3, 10, 30, 100 mg/kg) given SC after carbidopa, and piribedil (10, 30, 100, 300 mg/kg) had biphasic effects on investigation of a novel cup. Gerbils given a low dose of L-Dopa (10 mg/kg) or piribedil (10 or 30 mg/kg) investigated the cup more than did vehicle-injected gerbils, whereas those gerbils given a high dose of L-Dopa (100 mg/kg) or piribedil (300 mg/kg) investigated it less. L-Dopa, but not piribedil, also had biphasic effects on investigation of conspecific odors. The increase in duration with no increase in frequency of investigation suggested an inability to shift attention normally. High-dose attenuation of investigation is considered nonspecific, as many other drugs have the same effect. Locomotor activity scores showed no concomitant increase following low doses, but only a dose-dependent decrease. In addition, L-Dopa (100 mg/kg), but not piribedil at any dose tested, prevented the normal decrement in response to the cup 24 h after injection. As a high response is normally only shown when the stimulus is novel, the data suggest that L-Dopa at the high dose, but not piribedil, interfered with selective attention. Thus, the different dopamine agonists affected different aspects of attention. The data are di...Continue Reading

References

Jan 1, 1977·Schizophrenia Bulletin·B SpringS Matthysse
Jun 1, 1978·Behavioral Biology·R L IsaacsonD McClearn
Jul 16, 1979·Life Sciences·C DenefP A Janssen
Oct 1, 1979·Behavioral and Neural Biology·M L Cheal
Feb 18, 1977·Science·S M Antelman, A R Caggiula
Apr 5, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·R J Miller, L L Iversen
Sep 1, 1967·The Journal of Pharmacy and Pharmacology·N E AndénT Hökfelt
Sep 1, 1974·European Journal of Pharmacology·S GarattiniP L Morselli
Nov 1, 1972·European Journal of Pharmacology·H CorrodiU Ungerstedt
Sep 1, 1972·Journal of Comparative and Physiological Psychology·R W Thompson, L G Lippman
Jan 1, 1971·Psychopharmacologia·J MajE Mogilnicka
Jan 1, 1966·Psychological Review·R F Thompson, W A Spencer
Jan 1, 1970·European Journal of Pharmacology·N E AndénU Ungerstedt
Dec 1, 1982·Pharmacology, Biochemistry, and Behavior·M ChealL Silva
Feb 1, 1982·Journal of Comparative and Physiological Psychology·M L ChealV B Domesick
Mar 1, 1982·Pharmacology, Biochemistry, and Behavior·M Cheal
Sep 1, 1981·Behavioural Brain Research·D J Ingle
Oct 1, 1981·Behavioral and Neural Biology·M L Cheal
Sep 1, 1981·Behavioral and Neural Biology·R R Miller, A D Holzman
Mar 1, 1980·The Journal of Nervous and Mental Disease·B J Spring

❮ Previous
Next ❯

Citations

May 19, 1989·European Journal of Pharmacology·K IchiharaT Kameyama
Nov 1, 1991·Physiology & Behavior·J W Brock, C Prasad
Sep 5, 1998·Brain Research. Brain Research Reviews·G L Willis, S M Armstrong
Jan 1, 1986·Experimental Aging Research·M L Cheal
Nov 1, 1991·The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology·M ChealD C Hubbard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.